Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
(02 Dec 2025)

Back
Jubilant Pharmova has appointed Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the company.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew